Infuse Lawsuit
The Infuse bone graftis a bioengineered liquid bone protein that is supposed to encourage bone growth. Infuse is contained in a small container or cage that is implanted into the spine. Medtronic, Inc. is the manufacturer of Infuse. The Food and Drug Administration in 2002 approved Infuse for only one type of spine surgery, which was the anterior approach lumbar fusion. Infuse was not approved for other types of spine surgeries such as lateral or posterior approach lumbar fusion surgeries, nor for neck or cervical spine surgeries. Patients implanted with Infuse suffer from the following symptoms:
- uncontrolled bone growth
- difficulty swallowing
- difficulty breathing or speaking
- nerve injuries
- male sterility
- and some types of cancer
Lawsuits Against Medtronic
In June 2011, The Spine Journal disclosed that Medtronic paid researchers failed to report serious complications from Infuse, including cancer, sterility in men, infections, bone dissolution and worsened back and leg pain. The article said these complications occurred in 10 to 50 percent of patients who got the product.
If you have been implanted with a Medtronic Infuse Bone Graft and have suffered any of the side effects listed to the left, then please fill out our Infuse Lawsuit Case Inquiry Form below.
